Sabra Health Care REIT Inc

Sabra Health Care REIT Inc(SBRA)股票分析

$19.290

+0.122 (+0.63%)收盘时

Loading chart…
最高
19.670
开盘
19.610
成交量加权均价
19.40
成交量
2.19M
市值
3.50B
最低
19.255
成交额
42.44M
企业价值/息税折旧摊销前利润(TTM)
89.18

Sabra Health Care REIT Inc operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. The Company invests primarily in the United States nursing home industry, including skilled nursing and transitional care facilities, the United States and Canadian senior housing industry, which includes independent living, assisted living, memory care and continuing care retirement communities, select behavioral health and addiction treatment centers, and acute care and other hospitals. Its skilled nursing facilities provide services that include daily nursing, therapeutic rehabilitation, social services, activities, housekeeping, nutrition, medication management and administrative services for individuals.

AI 分析 of Sabra Health Care REIT Inc (SBRA)

持有

Sabra Health Care REIT Inc is currently a hold. The stock is trading at $18.96, which is below the analyst price targets of $21 to $25, suggesting potential upside. However, the RSI is at 31.401, indicating it is oversold, and the recent net loss of $0.10 per share in Q2 2026 raises concerns about profitability. The forward P/E ratio of 32.1543 suggests the stock may be overvalued relative to its earnings potential, which is a risk for long-term investors.

分析师评级(12)

上行空间 +7.98%
持有
4 买入
7 持有
1 卖出
当前: 19.29
最低
20.00
平均
20.83
最高
22.00

Huntington

2026-09-10

目标价

$23

跑赢大盘

Mizuho

2026-08-31

目标价

$21

中性

Barclays

2026-08-31

目标价

$23

Equal Weight

Raymond James

2026-08-06

目标价

—

Market Perform

Deutsche Bank

2026-07-22

目标价

$25

买入

估值指标

Sabra Health Care REIT Inc(SBRA)当前预期市盈率为 32.15,5 年平均预期市盈率为 31.74。

预期市盈率

合理
5 年均值 P/E
31.74
当前P/E
32.15
高估
54.05
低估
9.42

预期 EV/EBITDA

严重高估
5 年均值 EV/EBITDA
16.52
当前EV/EBITDA
89.18
高估
31.61
低估
1.43

预期市销率

合理
5 年均值 P/S
5.09
当前P/S
4.86
高估
5.64
低估
4.53

Alphio AI 对 SBRA 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%SBRA

$19.80

情景价格

基

基准

基准 · 50%SBRA

$16.16

情景价格

悲

悲观

悲观 · 25%SBRA

$13.50

情景价格

持有 SBRA 的大户

C

CenterSquare Investment Management LLC

+ 持有SBRA

-9.13%

3个月收益率

SBRA 常见问题 —— 由 Alphio AI 解答

Sabra Health Care REIT Inc operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. The Company invests primarily in the United States nursing home industry, including skilled nursing and transitional care facilities, the United States and Canadian senior housing industry, which includes independent living, assisted living, memory care and continuing care retirement communities, select behavioral health and addiction treatment centers, and acute care and other hospitals. Its skilled nursing facilities provide services that include daily nursing, therapeutic rehabilitation, social services, activities, housekeeping, nutrition, medication management and administrative services for individuals. It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).

Sabra Health Care REIT Inc is currently a hold. The stock is trading at $18.96, which is below the analyst price targets of $21 to $25, suggesting potential upside. However, the RSI is at 31.401, indicating it is oversold, and the recent net loss of $0.10 per share in Q2 2026 raises concerns about profitability. The forward P/E ratio of 32.1543 suggests the stock may be overvalued relative to its earnings potential, which is a risk for long-term investors.

12 analysts cover SBRA: 4 rate it Buy, 7 Hold and 1 Sell. The average price target is 20.83.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易